Minister of Health Mike Nesbitt Visits Randox Laboratories to Discuss Research and Achievements
Mike Nesbitt, the Minister of Health, visited Randox Laboratories today to explore the company’s groundbreaking current projects and celebrate its recent achievements in the diagnostic industry. As the UK’s largest blood-science diagnostic company, active in over 145 countries supplying to over 100,000 laboratories globally, Randox are committed to reduce burdens on healthcare, improve patient outcomes and advance medical decisions.
R&D investment has always been a strong commitment at the heart of Randox, with an investment of up to 25% of turnover into spearheading diagnostics, looking at current healthcare challenges, chronic illnesses and economic burdens. Randox’s focus is on the need for change from sickness to prevention, from hospitals to communities and from analogue to digital advancements.
Director of Business Development, Dr Mary Jo Kurth, commented:
“Randox are at the forefront of diagnostics, collaborating closely with clinicians to address the most pressing clinical challenges. Our portfolio includes many innovative products, all designed with a focus on early diagnosis. This approach not only improves patient outcomes but also significantly reduces healthcare costs.”
The visit highlights Randox’s continued commitment to pioneering cutting-edge technologies and its significant contributions to healthcare both locally and globally.
Minister Nesbitt commented:
“I would like to thank Randox for the opportunity to see first-hand the work it is undertaking. It is evident that Randox has a dedicated workforce and I am very pleased to learn more about their recent projects and achievements.”